(S)-(+)-2-Fluoro-α-Methyl-4-Biphenylacetic Acid
CAS : 51543-39-6
Ref. 3D-FF92467
1g | Arrêté | ||
2g | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- (+)-(S)-Flurbiprofen
- (+)-Flurbiprofen
- (2S)-2-(2-Fluoro-1,1′-biphenyl-4-yl)propanoic acid
- (2S)-2-(2-Fluoro-4-biphenyl)propanoic acid
- (2S)-2-(2-fluorobiphenyl-4-yl)propanoic acid
- (S)-2-(2-Fluoro-[1,1′-biphenyl]-4-yl)propanoic acid
- (S)-2-(2-Fluoro-[1,1′-biphenyl]-4-yl)propanoicacid
- (S)-2-(2-Fluorobiphenyl-4-yl)propanoic acid
- (S)-2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid
- (S)-2-Fluoro-alpha-methyl-4-biphenylacetic acid
- Voir d'autres synonymes
- (αS)-2-Fluoro-α-methyl[1,1′-biphenyl]-4-acetic acid
- 2-(2-Fluorobiphenyl-4-Yl)Propanoic Acid
- Dexflurbiprofen
- Esflurbiprofene [French]
- Esflurbiprofeno [Spanish]
- Esflurbiprofenum [Latin]
- Unii-J5Zzk9P7Mx
- [1,1′-Biphenyl]-4-acetic acid, 2-fluoro-α-methyl-, (S)-
- [1,1′-Biphenyl]-4-acetic acid, 2-fluoro-α-methyl-, (αS)-
- d-Flurbiprofen
(S)-(+)-2-Fluoro-alpha-Methyl-4-Biphenylacetic Acid is a synthetic compound that inhibits oxidative phosphorylation by binding to the enzyme succinate dehydrogenase. This inhibition in cellular respiration leads to the depletion of ATP and an increase in ADP, AMP, and NADH. (S)-(+)-2-Fluoro-alpha-Methyl-4-Biphenylacetic Acid has been shown to be effective against metabolic disorders such as hyperproliferative disease and diabetic neuropathy, as well as pain models. It also has the ability to cross the blood brain barrier, which makes it an attractive option for treating central nervous system disorders.